A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma

van den Bent, Martin; Azaro, Analia; De Vos, Filip; Sepulveda, Juan; Yung, W. K. Alfred; Wen, Patrick Y.; Lassman, Andrew B.; Joerger, Markus; Tabatabai, Ghazaleh; Rodon, Jordi; Tiedt, Ralph; Zhao, Sylvia; Kirsilae, Tiina; Cheng, Yi; Vicente, Sergio; Balbin, O. Alejandro; Zhang, Hefei; Wick, Wolfgang

dc.contributor.author	Tabatabai, Ghazaleh
dc.date.accessioned	2020-08-05T11:13:28Z
dc.date.available	2020-08-05T11:13:28Z
dc.date.issued	2019
dc.identifier.issn	1573-7373
dc.identifier.uri	http://hdl.handle.net/10900/104459
dc.language.iso	en	de_DE
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s11060-019-03337-2
dc.subject.ddc	610	de_DE
dc.title	A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200409032300_00391
utue.publikation.seiten	79-89	de_DE
utue.personen.roh	van den Bent, Martin
utue.personen.roh	Azaro, Analia
utue.personen.roh	De Vos, Filip
utue.personen.roh	Sepulveda, Juan
utue.personen.roh	Yung, W. K. Alfred
utue.personen.roh	Wen, Patrick Y.
utue.personen.roh	Lassman, Andrew B.
utue.personen.roh	Joerger, Markus
utue.personen.roh	Tabatabai, Ghazaleh
utue.personen.roh	Rodon, Jordi
utue.personen.roh	Tiedt, Ralph
utue.personen.roh	Zhao, Sylvia
utue.personen.roh	Kirsilae, Tiina
utue.personen.roh	Cheng, Yi
utue.personen.roh	Vicente, Sergio
utue.personen.roh	Balbin, O. Alejandro
utue.personen.roh	Zhang, Hefei
utue.personen.roh	Wick, Wolfgang
dcterms.isPartOf.ZSTitelID	Journal of Neuro - Oncology	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	146	de_DE
utue.fakultaet	04 Medizinische Fakultät
utue.fakultaet	Sonstige